Skip to content

Clinical trials

Phase 3 Seizures trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Seizures Phase: Phase 3 Country / region: Portugal Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20191
20223
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Enrolling by invitation2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Longboard Pharmaceuticals3
Xenon Pharmaceuticals Inc.3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Eisai Inc.1
SK Life Science, Inc.1
UCB Biopharma SRL1
Zogenix, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Seizures12
Epilepsy9
Lennox Gastaut Syndrome3
Neurodevelopmental Disorders3
Epilepsies, Myoclonic2
Epilepsies, Partial2
Drug Resistant Epilepsy1
Epilepsy, Tonic-Clonic1
Spasms, Infantile1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.